163 related articles for article (PubMed ID: 31081078)
1. Long non-coding RNA cancer susceptibility candidate 2 inhibits the cell proliferation, invasion and angiogenesis of cervical cancer through the MAPK pathway.
Wang XW; Zhang W
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3261-3269. PubMed ID: 31081078
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancer.
Zhou J; Huang H; Tong S; Huo R
Mol Med Rep; 2017 Oct; 16(4):5235-5240. PubMed ID: 28849111
[TBL] [Abstract][Full Text] [Related]
3. The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.
Sun J; Liu L; Zou H; Yu W
Yonsei Med J; 2019 Oct; 60(10):905-913. PubMed ID: 31538425
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway.
Huang F; Zhang Q; Chen W; Zhang H; Lu G; Chen J; Qiu C
J Cell Biochem; 2019 Jun; 120(6):10380-10390. PubMed ID: 30609134
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CASC2 regulates cell biological behaviour through the MAPK signalling pathway in hepatocellular carcinoma.
Gan Y; Han N; He X; Yu J; Zhang M; Zhou Y; Liang H; Deng J; Zheng Y; Ge W; Long Z; Xu X
Tumour Biol; 2017 Jun; 39(6):1010428317706229. PubMed ID: 28621238
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA cancer susceptibility candidate 2 inhibits tumor progression in osteosarcoma.
Lu L; Dai Z; Luo Q; Lv G
Mol Med Rep; 2018 Jan; 17(1):1947-1953. PubMed ID: 29257211
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of lncRNA CASC2 facilitates osteosarcoma growth and invasion through miR-181a.
Ba Z; Gu L; Hao S; Wang X; Cheng Z; Nie G
Cell Prolif; 2018 Feb; 51(1):. PubMed ID: 29194827
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway.
Liao Y; Shen L; Zhao H; Liu Q; Fu J; Guo Y; Peng R; Cheng L
J Cell Biochem; 2017 Jul; 118(7):1889-1899. PubMed ID: 28121023
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of lncRNA CASC2 promotes cell proliferation and metastasis of bladder cancer by activation of the Wnt/β-catenin signaling pathway.
Pei Z; Du X; Song Y; Fan L; Li F; Gao Y; Wu R; Chen Y; Li W; Zhou H; Yang Y; Zeng J
Oncotarget; 2017 Mar; 8(11):18145-18153. PubMed ID: 28199978
[TBL] [Abstract][Full Text] [Related]
14. Long non‑coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer.
Xue Z; Zhu X; Teng Y
Mol Med Rep; 2018 Dec; 18(6):5173-5181. PubMed ID: 30320385
[TBL] [Abstract][Full Text] [Related]
15. E2F6-mediated lncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma.
Li Y; Jiang L; Lv S; Xu H; Fan Z; He Y; Wen H
Life Sci; 2019 Sep; 232():116649. PubMed ID: 31301415
[TBL] [Abstract][Full Text] [Related]
16. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma.
Peng L; Liu YH; Nie S; Gao M
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8367-8376. PubMed ID: 32894543
[TBL] [Abstract][Full Text] [Related]
18. MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
Wei YQ; Jiao XL; Zhang SY; Xu Y; Li S; Kong BH
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7314-7326. PubMed ID: 31539118
[TBL] [Abstract][Full Text] [Related]
19. Reduced long non-coding RNA PTENP1 contributed to proliferation and invasion via miR-19b/MTUS1 axis in patients with cervical cancer.
Ou L; Xiang TY; Hao XY; Wang DZ; Zeng Q
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4132-4144. PubMed ID: 32373949
[TBL] [Abstract][Full Text] [Related]
20. Modulation of CASC2/miR-21/PTEN pathway sensitizes cervical cancer to cisplatin.
Feng Y; Zou W; Hu C; Li G; Zhou S; He Y; Ma F; Deng C; Sun L
Arch Biochem Biophys; 2017 Jun; 623-624():20-30. PubMed ID: 28495512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
